Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GulfSpore is a biotechnology company specializing in the fermentation and production of Bacillus spore-based probiotics for the healthcare and nutraceutical industries. Based in Ocean Springs, Mississippi, the company operates a state-of-the-art facility dedicated to culturing high-purity, DNA-verified microbial strains such as Bacillus subtilis HU58 and Bacillus indicus HU36. GulfSpore provides both bulk raw materials and comprehensive contract manufacturing services, including formulation and encapsulation. Their expertise focuses on the unique resilience of endospores, which offer superior stability and survivability through the gastric environment compared to traditional probiotics. The company serves as a primary supplier for leading professional-grade supplement brands and clinical practitioners. By leveraging advanced fermentation technologies, GulfSpore ensures that their microbial products maintain high potency and therapeutic efficacy for gut microbiome support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gulf Spore.